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Summary: No convincing support has been provided so far for the existence of extrahepatic hepatitis C virus
particles that should correspond to the sometimes extremely high concentration of 'HCV-RNA' in serum or plasma.
If a naturally occuring HCV-specific DNA were to be found, a concept for at least some phenomena in terms of
the pathophysiology of HCV should become conceivable. DNA was extracted from peripheral blood mononuclear
cells of eleven healthy, anti-HCV-negative individuals, including five long term blood donors, and cells from
different cell lines. DNA was subjected to nested polymerase chain reaction omitting a reverse transcriptase step
with primers of the 5'NC as well as part of the core region of HCV. Direct polymerase chain reaction, i. e. without
a reverse transcriptase step, revealed HCV-specific sequences in the DNA fraction of peripheral blood mononuclear
cells of different origin: healthy anti-HCV negative individuals, furthermore in HeLa and MT2 cells. The fragments
found were of expected length as well as of shorter and of longer than expected length with respect to the sequence
of the HCV genome framed by the primers applied. The results derived from additional hybridization, restriction
endonuclase analysis, and sequencing demonstrated HCV-specific sequences in the expected fragments with both a
high degree of homology and deletions, respectively, substitutions, as compared to a prototype strain. However, the
longer than expected fragments also contained sequences not specific for HCV.
Introduction
The detection of HCV specific DNA sequences in tissue
samples of liver from anti-HCV positive German intra-
venous drug users and Chinese patients with primary
hepato-cellular carcinoma (1) was accomplished utiliz-
ing primers for direct polymerase chain reaction (dPCR,
i. e. without a reverse transcriptase step) spanning parts
of the 5'NC- and C-regions. One of the most probable
reasons for the relatively low rate of detection was sup-
posed to be the selection of primers used in previous
investigations. We therefore decided to select other
primer sets that span shorter fragments, especially from
a 5'NC and C section of HCV not loaded with stem loop
structures. This was done with regard to mounting hints
that the 5*NC region is exceptionally important for the
development and maintenance of the chronic stage of
HCV infection and possibly the development to hepato-
cellular carcinoma (2, 3). In our previous investigations
we have already obtained indications of HCV specific
sequences being present in the DNA of individuals test-
ing anti-HCV negative. Therefore, both peripheral blood
mononuclear cells from healthy, anti-HCV negative in-
dividuals, one patient with acute hepatitis C, and dif-
ferent cell lines were included in the present study.
Materials and Methods
Sources for DNA and RNA extraction
Isolation of peripheral blood mononuclear cells
From eleven healthy, anti-HCV negative individuals, and one pa-
tient with acute hepatitis C, 10 ml venous blood were drawn and
immediately adjusted with EDTA-Na to give a final concentration
of 5 mmol/1. This EDTA-plasma (10 ml) was mixed with 10 ml
phosphate-buffered saline with EDTA-Na, l mmol/1, pH 7.8. This
mixture was layered onto 15ml Histopaque, density 1.077 kg/1
(Sigma, München, Germany) and centrifuged for 20 min at 1080
min"1 (200 g) at 20 °C. Three ml of the upper part of the superna-
tant was recovered and stored for further assays and the cell-con-
taining layer above the histopaque collected. The cells were sedi-
mented at 1080 min~' and resuspended in phosphate-buffered sa-
line (plus 10 mmol/1 EDTA-Na). This washing step was repeated
two times. Finally, the cell harvest was resuspended in 1 ml phos-
phate-buffered saline (plus 10 mmol/1 EDTA-Na) and used for ex-
traction of DNA (see below).
HeLa (cervical carcinoma), H9 and MT2 (T-cell lines) cells
Cells were taken from
(i) frozen (-70 °C) samples of cell cultures that had been stored
without any handling since 1988, i. e. long before any experiments
concerning HCV had been conducted in our laboratories.
(ii) Cells were also taken from continuous cell culture passages.
Cell culture passages were performed according to standard pro-
cedures in MEM(E) (Biochrom, Berlin, Germany) for HeLa cells,
and RPMI (Biochrom) for H9 and MT2 cells. The media were both
supplemented with newborn calf serum (Biochrom).
900 Dennin and Chen: Hepatitis C virus specific sequences as part of the human DNA
(iii) Additionally, we assayed two commercial genomic HeLa DNA
preparations (ITC/Clontech, Heidelberg, Germany): One sample
was ordered and investigated 5/1994, and another one in 7/1995.
Enzyme immunoassay ofHCV antibodies
The anti-HCV EIA (Abbott, Wiesbaden, Germany), RIBA 2 resp.
3 (Ortho, Neckargmund, Germany) and Matrix (Abbott) assays in
sera were performed according to the manufacturer's instruction.
Extraction of deoxyribonucleic acid
The procedures were the same as outlined in a previous paper (1).
In brief: A cell pellet from the final harvest (see above) was di-
gested with proteinase K (0.1 g/l, Tris EDTA buffer pH 8.0: Tris 10
mmol/1, EDTA 1 mmol/1), extracted twice with phenol/chloroform/
isopropanol (25 + 24 + l, pH 7.9) and twice with chloroform/iso-
propanol (24 + 1). After precipitation with ethanol, the pellet was
washed twice with ethanol (volume fraction 0.70) and dissolved
in 100 μΐ buffer containing Tris/HCl 10 mmol/1, EDTA 1 mmol/1,
pH 8.O.
Polymerase chain reaction (PCR)
Oligonucleotides: HCV specific primers were synthesized with the
Pharmacia 'Genas sembler plus' and by MWG (Ebersberg, Ger-
many), respectively: They were chosen from different conserved
regions of the HCV genome according to published data (see
fig. 1). 5"NC-region: set la and set Ib; 5*NC-C region= set 2a and
set 2b. For some applications the primers of set Ib and 2b (inner
primers) and probes were labelled at their 5'-end with biotin (BIO-
DITE™, Biotin Amidite, Pharmacia, Freiburg). The sequences of
all primers and probes used in this study were checked for homol-
ogy with the sequence of the HCV strain published by Choo et al.
(5) (source: EMBL, Heidelberg) with the Genmon 5 program
(GBF, Braunschweig, Germany). Both reaction mixture and PCR
methodology were essentially the same as outlined previously (1),
with one exception. The denaturing step was only for l min instead
of 1.5 min at 94 °C; and only 30 cycles were applied instead of 35
cycles. Two rounds of PCR were done because of using the visible
fragments after gel electrophoresis for cloning and sequencing. Ex-
traction of the fragments in question from the gels for cloning and
sequencing was done according to manufacturer's protocol (Agar-
ose gel extraction kit, Boehringer, Mannheim).
Safety procedures to avoid contaminations were follwed according
to the state of the art, especially the use of separate rooms for
each step of the PCR procedure. When setting up a PCR assay the
arrangement for the reaction tubes was as follows:
1. negative control, i.e., a complete reaction mix, but without a
DNA matrix,
2. complete reaction mix with a preparation that could contain
DNA,
3. negative control, etc.; the arrangements shown in figures 2 and
3 were made by loading the gel slots with selected products after
direct PCR for comprehensive demonstration.
Hybridization and detection of labelled fragments
The procedures were the same as outlined previously (1). The de-
velopment of biotin labelled probes or fragments (via 5'-biotin
labelled primers) after transfer to a positively charged Nylon mem-
brane was done with anti-biotin labelled peroxidase (Boehringer,
Mannheim) according to the manufacturer's instructions.
Alternatively we used digoxigenin labelled probes (PTNC-P) (DIG
Oligonucleotide 3'-End Labelling Kit and DIG Nucleic Acid Detec-
tion Kit, Boehringer, Mannheim) beside those labelled with biotin.
Sequence analysis
Fragments after PCR and gel electrophoresis were cloned with the
TA Cloning kit, pCR2.1 Vector (INVITROGEN, Leek, Nether-
lands). For sequencing, the Dig Taq DNA sequencing kit (Boeh-
ringer, Mannheim) was used or sequencing was done by MWG
(Ebersberg, Germany). Searches for sequence homologies were
conducted with the DNA databank at the EMBL (Heidelberg, Ger-
many).
Enzymatic1) analysis
The restriction endonucleases Avail, Hpall and Smal (Pharmacia,
Freiburg) were used according to the manufacturer's instructions.
DNase and RNase challenge: DNase, 20 units per 50 μΐ (400 kU/1)
final concentration (RNase free, Boehringer) and RNase, 20 mg/1
final concentration (DNase free, Boehringer) were applied accord-
ing to the manufacturer's instructions.
Results
In the present study we have been looking for naturally
occuring HCV DNA with primers of the 5*NC- and C-
region for the nested direct PCR protocol (i.e. PCR
without a preceding reverse transcriptase step) in dif-
ferent sources for DNA. Peripheral blood mononuclear
cells from healthy, anti-HCV negative individuals, some
of them registered blood donors, cells from continuous
cultures: HeLa, H9 and MT2 (the status with regard to
an 'HCV infection' of those source individuals is not
known), and one case of an acute hepatitis C. Products
after direct PCR were assayed by hybridization, restric-
tion endonuclease fragment length analysis, and mostly
sequencing. Of the peripheral blood mononuclear cells
samples from healthy individuals (four females, seven
males) 10/11 (set 1 primers) and 7/8 (set 2 primers) (de-
tails for location of primers see fig. 1) assayed samples
had fragments containing HCV specific sequences. In
the present paper we have focused on the fragments gen-
erated by direct PCR with set la,b primers. In the posi-
tive cases the nested direct PCR yielded fragments of
the expected length in 9/11, in 1/11 one shorter than
expected and in 5/11 additional longer fragments were
obtained (selected cases are shown in figs 2a-c). From
certain anti-HCV negative individuals blood was drawn
a second time three weeks later and the DNA extracted
from peripheral blood mononuclear cells. The results,
i. e. the individual 'band pattern' (= the relative position
of fragments of different length in the gel) were identical
for the given individual thus excluding a contamination.
However, peripheral blood mononuclear cells samples
prepared later showed fragments of longer than expected
length at different positions (see below for details). The
specificity was assayed by hybridization (fig. 2b) with a
probe (PTNC-P) whose sequence is located between the
inner primers of set 1. The corresponding stronger band
') Enzymes
DNasel (RNase-free): Deoxyribonuclease I (EC 3.1.21.1)
Proteinase K: Endopeptidase K (EC 3.4.21.64)
Restriction enzymes: Type II site-specific deoxyribonuclease (EC
3.1.21.4)
RNase I (DNase-free): Pancreatic ribonuclease (EC 3.1.27.5)
Taq polymerase: DNA-directed DNA polymerase (from Thermus
aquations) (EC 2.7.7.7)
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I Avail
1 I Hpall
1 Smal
Sample no: 3 CDZ1
la: PTNC-E1 χ PTNC-E2
-> <-
Ib: PTNC-I1 χ PTNC-I2
<-PTNC-P
2s. : BC-E1 Χ ΒΒ-Ε2
BC-I1 Χ ΒΒ-Ι2
<— AE2-P
Fig. 1 Hepatitis C virus: 5'NC and C region of the genome with
location of primers, probes, and cutting sites of restriction enzymes
used (Avail, Hpall, and Smal).
A: Relative arrangement of genomic regions: NC = non-coding,
C = core (nucleocapsid).
B: Primers used, in brackets the nucleotide number is given accord-
ing to the prototype HCV strain described by Choo et al. (5)
(EMBL, Heidelberg). References are given in parenthesis.
5TSfC-region:
set la: PTNC-E1 [89-108], PTNC-E2 [152-170],
set Ib: PTNC-I1 [99-118], PTNC-I2 [139-158],
PTNC-P = digoxigenin labelled probe [122-141] (24);
5'NC-C region:
set 2a: BC-E1 [268-297], BB-E2 [387-416];
set 2b: BC-I1 [284-305], BB-I2 [381-403]; AE2-P = digoxi-
genin labelled probe [299-328] (25);
-E.: external, -I.: internal, -.1: sense, -.2: antisense;
< > arrows indicate broadly the start position of primers,
I arrows indicate broadly the cutting sites of the restriction en-
zymes used here.
of the gel (e. g., arrow: '[>' lane 6, « 115 base pairs, fig.
2a) containing longer fragments than expected did not
yield a strong signal after hybridization. The restriction
endonuclease fragment length analysis also gave results
not in accordance with the assumption of regular unique
arrangements of the sequence according to the 'HCV-
RNA genome'. The fragments of expected length were
cut (arrows: *>', figs 2a and b) resulting in smaller frag-
ments, whereas the longer fragments remained un-
changed (fig. 2a). After restriction endonuclease frag-
ment length analysis with Hpall and Smal the products
of the digest with the expected fragment (lane 6, fig. 2a)
could no longer be hybridized with the PTNC-P probe
for set 1, whereas the digest by Avail showed positive
signals with the same probe (fig. 2b). This is to be ex-
pected because Hpall and Smal cut within the sequence
matching the probe, however, Avail cuts outside thus
leaving the sequence matching that of the probe.
Furthermore, serum samples from three healthy individ-
uals enrolled in this study were also assayed for HCV-
RNA by reverse transcriptase PCR with set 1 primers.
After gel electrophoresis fragments of the expected
length were present, and for one case (individual 2:
lanes 6 to 9, fig. 2a) an additional fragment of longer
than expected length was also present (results not shown
here). The data show the fragment at the expected posi-
tion to contain the respective sequence ("e", fig. 4) of
Base pairs
lanes 1,18
124,123
h— 64
0
·<«*
5 10 15 17
C Base pairs
lanes M
400
100
Fig. 2 a) Results after direct PCR (primer set Ib, see fig. 1) and
restriction endonuclease fragment length analysis (RFLA) of DNA
prepared from peripheral blood mononuclear cells of healthy anti-
HCV negative individuals. Samples 1 (lanes 2-5), 2 (lanes 6-9),
3 (lanes 10—13), and CDZ1 (= cloned fragment of the 5'NC region
covering nucleotides 66 to 321) positive control (lanes 14-17).
Lanes 3, 7, 11, and 15 after digest with Hpall; lanes 4, 8, 12, and
16 with Smal; lanes 5, 9, 13, and 17 with Avail respectively. The
bands at the expected position (arrow: '>'; no 2 = sequence "e",
fig. 4) can be digested by all enzymes, the longer bands of 2 (ar-
row: '()') and 3 cannot. Lanes 1 and 18, molecular mass marker
(Boehringer type V). The samples shown in the lanes were taken
from different PCR assays and arranged here for this picture. The
arrangement of loading the slots in the original gel is always:
blank/sample/blank/sample/blank etc.; gel electrophoresis in 2%
agarose.
b) Hybridization with digoxigenin labelled oligo-PTNC probe
(= PTNC-P, see fig. 1) after direct PCR and restriction enzyme
analysis (same arrangement as shown in part a); lanes 2, 6, 10 and
14, all bands of the untreated samples (= without restriction en-
zyme digest) at the expected position show positive signals; lanes
6 to 9, the longer band of 2 (~ 115 base pairs, arrow: '[)') presents
weakly; lanes 10 to 13, the longer band of 3 (= 85 base pairs,
arrow: '-*') presents very weakly, only visible on the original
membrane (at higher temperature 57 °C instead of 54 °C these
bands are no longer visible).
c) Results after direct PCR (primer set Ib) of DNA from peripheral
blood mononuclear cells of additional healthy anti-HCV negative
individuals in lanes 2-5. Lane 1, blank (negative) control: PCR
master mix without any target DNA; lane 2, same individual (sam-
ple 1) as shown in lanes 2—5, fig. 2a but here peripheral blood
mononuclear cells prepared from a sample taken 40 months later;
lane 3, is the same individual (sample 2) as shown in part 2a, but
here peripheral blood mononuclear cells prepared 40 months later;
lane 4, shows a shorter than expected fragment; lane 5, healthy
individual; lane 6, blank control: PCR master mix with pUC18
plasmid DNA, 100 ng; lane 7, CDZ1 positive control (see part 2a);
lanes M, molecular mass marker, 100 base pair ladder; arrows '>'
and '<' point at the fragments of expected length = 60 base pairs;
sequences see figure 4; arrows '«—' pointing at the 100 and 400
base pair fragments of the molecular mass marker; gel electropho-
resis in 4% agarose.
the HCV reference strain2). From this individual (fig. 2)
further DNA preparations from peripheral blood mono-
2) In this manuscript only the data after sequencing of the frag-
ments of expected length are considered, the respective data of
the longer than expected fragments are not discussed (manuscript
in preparation).
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nuclear cells 16 months (8/1995) and 40 months later
were analyzed with the same primers by direct PCR.
The results after gel electrophoresis and hybridization
show a different pattern: besides the fragment of ex-
pected length, two fragments of 'longer than expected
length' were present in 8/1995 (results not shown here)
and only one additional longer fragment in 8/1997 (lane
3, fig. 2c). From another healthy individual a fragment
of shorter than expected length was detected. The se-
quence shown in lane 4, figure 2c presents a deletion of
14 nucleotides and two single point substitutions, see
sequence "c", figure 4. The sequencings were done on
both strands of the cloned fragments. The sequences are
identical for both strands in "c", "d", "f', and "g". For
"e", the sequence for only one strand was available. For
sequence "b" one strand is identical to the respective
region of the reference strain, the other strand shows one
C-nucleotide less in the 'CCCCCCC'-section. We think
this deletion to be due to the sequencing procedure.
We further extended the search for HCV specific se-
quences in the DNA of quite different cell lines used in
our laboratory for virus propagation HeLa, H9 and MT2.
These cell lines were passaged in a special laboratory
for cell cultures that had never been in contact with any
step of PCR. After direct PCR with the set 1 as well as
the set 2 primers (see fig. 1) followed by gel electropho-
resis we were able to obtain positive signals from HeLa,
H9 and MT2 cells at the expected positions (arrows: '[)',
figs. 3a,b), and partly additional single longer or
multiple longer than expected fragments (arrows: '—»',
figs. 3a,b, all for primer set 1). The 'band pattern' was
different among the cell lines used here but was the
Base pairs
lane 6
458,434
234
124,123
Approximate
position
350
225
130
Fig. 3 a) Results after direct PCR with PTNC primers (set Ib)
with DNA from different cell culture lines. Lane 1, HeLa; lane 2,
H9; lane 3, MT2; lane 4, negative control = PCR buffer including
primers and Tag polymerase, without target DNA; lane 5, positive
control = CDZ1; lane 6, molecular mass marker (Boehringer type
V) with arrows '«—' pointing at selected positions,
b) Results after blotting and hybridization with digoxigenin la-
belled oligo-PTNC probe (PTNC-P, see fig. 1) of the gel shown in
part a (= same arrangement). The longer (containing fragments of
higher molecular mass than expected) bands at = 225 base pairs
(lane 1) and at « 130, « 225 and = 350 base pairs (MT2) (small
arrows: '—»') show positive signals beside the expected band (ar-
row: '[>'). H9 does not show any signal after hybridization.
same for a given sample upon repetition, when using
material from a new extraction.
Furthermore we employed genomic HeLa DNA from
inhouse cell cultures extracted and stored at —70 °C
since 1988 as well as two different lots of genomic HeLa
DNA purchased from ITC-Clontech: the 'band pattern'
after direct PCR in the gel was similar although not
identical concerning the position in the gel to those used
from our laboratory (s. Material and Methods). The hy-
bridization with the PTNC-P probe for set 1 primers
gave positive signals only for the HeLa and MT2 cells
(fig. 3b). Whether the lacking signal after hybridization
in lane 2, figure 3b, for H9 cells is due to the absence
of a real fragment or a fragment either with insufficient
or lacking homologous sequence for the PTNC-P probe
to anneal remains to be clarified by further cloning and
sequencing investigations. However, as no signal after
hybridization was found for H9-DNA after direct PCR
upon all repetitions performed, exclusion of laboratory
contamination is warranted. According to the DNA mo-
lecular mass marker the primers are positioned just in
front of the bands with the expected fragment length.
They do not hybridize with the PTNC-P probe (lane 4 =
negative control, fig. 3b). Although the bands containing
longer than expected fragments within the gel (arrows:
'—>' « 130 base pairs, « 225 base pairs, « 350 base
pairs, fig. 3a) appear stronger than the expected frag-
ments, their signal after hybridization presents weaker
or even negative (fig. 3b).
Further experiments were performed to assay for the pos-
sibility of unspecific priming by e. g. internal fragments
of the same DNA that might be present in these prepara-
tions of high molecular weight DNA from human cells.
1. By conducting the direct PCR (strictly according to
the protocol used) without primers, no bands could be
detected either with otherwise positive samples or with
DNA from peripheral blood mononuclear cells, HeLa,
H9 and MT2 cells.
2. PCRs were conducted during the 'nested' round with
PTNC-I1 and -12 primers (set Ib) whose 5'-ends had
been labelled with biotin (see Material and Methods).
After development with anti-biotin labelled peroxidase
the same pattern could be demonstrated with regard to
the position of bands (results not shown).
3. The hot start protocol for PCR was applied. However,
the band pattern, i. e., 'fragments of expected as well as
of longer than expected length' remained unchanged.
4. The temperature of the primer annealing step of the
PCR was adjusted up to 60 °C — but again the band
pattern remained the same.
5. The fragments obtained after direct PCR proved spe-
cific for a DNA target: The matrix for direct PCR turned
out to be sensitive for DNase treatment but not for
RNase treatment of the cell extracts.
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a: AGTGTCGTGCÄGCCTCCAGGACCCCCCCTCCCGGGÄGAGCCATÄGTGGTCTGCGGAACCG
b: AGTGTCGTGCAGCCTCCAGGACCCCCCCTCCCGGGAGAGCCATAGTGGTCTGCGGAACCG
c:AGTGTCGTGCAGCCTCCAGG GAaAGtCATAGTGGTCTGCGGAACCG
d:AGTGTCGTGCAGCCTCCAGGACCCCCCCTCCCGGGAGAGCCATAGTGGTCTGCGGAACCG
e:AGTGTCGTGCAGCCTCCAGGACCCCCCCTCCCGGGAGAGCCATAGTGGTCTGCGGAACCG
f:AGTGTCGTGCAGCCTCCAGGACCCCCCCTCCCGGGAGAGCCATAGTGGTCTGCGGAACCG
g: AGTGTCGTGCAGCCTCCAGGACCCCCCtTCCCGGGAGAGCCATAGTGGTCTGCGGAACCG
h: ******************** **_**_********************
Fig. 4 The alignment of sequences amplified with the primer set
la,b, framing the 'expected' fragment of 60 base pairs; a: The
sequence of the HCV strain used as a reference (5), the sequences
of the sense and antisense primers are underlined; b: healthy indivi-
dual, lane 2, figure 2c; c: healthy individual, lane 4, figure 2c; d:
healthy individual, lane 5, figure 2c; e: healthy individual (4/1994),
6. The individual 'band patterns' were reproducibly ob-
tained upon repeating the direct PCR assays with the indi-
vidual extracts of DNA up to six times; when challenged
by hybridization of RFLA the results were identical.
7. By conducting the direct PCR including all components,
however, only pUC 18 plasmid DNA as a target was ap-
plied; no signal after gel electrophoresis was obtained.
Discussion
Although early investigators failed to detect a naturally
occuring HCV-DNA (4) others have found HCV spe-
cific DNA sections in the DNA fraction of anti-HCV
positive patients (1).
An intriguing situation was obtained after direct PCR
with DNA from peripheral blood mononuclear cells
from healthy anti-HCV negative individuals: When dif-
ferent primers are applied, fragments of the expected
length as well as in some cases fragments of higher rela-
tive molecular mass than expected, and in one case a
shorter than expected fragment were obtained from these
new samples. Furthermore, in HeLa and MT2 cell lines
HCV specific sequences could be detected, fragments of
the expected length as well as longer ones.
The contrary results following hybridization (i.e., gel
positive, hybridization negative) and restriction endonu-
clease fragment length analysis (i. e., gel positive, restric-
tion endonuclease fragment length analysis negative) (see
fig. 2a, b) become explainable by sequencing data. The se-
quences bordered by the primers contained in the longer
fragments of selected cases show sections of up to 9 or
10 nucleotides matching the respective HCV sequences of
that region (sequences not shown here). This is just ade-
quate to give a weak signal due to partial hybridization at
normal stringency conditions when compared to full
matching sites in the fragments of expected length which
yield strong signals upon hybridization. Ubiquitin spe-
cific sequences as shown for a pestivirus, bovine viral
diarrhea virus (6) could be excluded in these sequences by
conducting a direct PCR with ubiquitin specific primers.
A similar situation has to be considered for restriction en-
donuclease fragment length analysis: for example, the se-
quences available show the longer fragment in lanes 6 to
short fragment of expected size of lane 6, arrow '>', figure 2a; f:
same healthy individual as in "e", but this sample taken 8/1997,
lane 3, figure 2c; g: patient suffering from acute hepatitis C (the
result after gel electrophoresis is not shown here); h: In this line,
positions marked: '*' are totally conserved, '-'are variable while
periods "." indicate regions containing deletions.
9 (arrow: =>, fig. 2a) not to contain sites for the restriction
endonucleases applied. Although few samples have been
investigated, the rate of positive results with primer sets
downstream of the 5'NC region is lower with respect to
those of the 5'NC region itself. This could reflect its im-
portance in regulatory activities warranted by highly con-
served sequences with only a small degree of variation
(2). The fragments of the expected length show a com-
plete homology with the sequence of the prototype HCV
strain (5) for 3/4 cases of healthy anti-HCV negative in-
dividuals. This degree of homology has to be seen with
respect to the DNA matrix used here for the PCR target.
This DNA has been generated in vivo by cellular DNA
polymerases known to have excellent capability of proof-
reading compared with RNA polymerases. Therefore,
mutations are almost not expected when using such a
DNA matrix. However, in 1/4 cases a shorter than ex-
pected fragment (see lane 4, fig. 2c) was detected, the se-
quence of revealed a deletion of 14 nucleotides (no. 118
to 132 of the sequence used for reference (5)) and two sub-
stitutions at positions 135 and 138, respectively. A second
blood sample of this individual was taken six weeks later
and the peripheral blood mononuclear cells prepared:
again, only the shorter than expected fragment was de-
tected after direct PCR. The sequence of the expected
fragment of the one patient with acute hepatitis C shows a
substitute at position nt 126.
Since no reverse transcriptase has been detected together
with 'HCV, it seems unlikely that these HCV specific
DNA sequences are integrated ones derived from exter-
nal RNAs. The alternative, that the fragments detected
were generated by foreign reverse transcriptase activities
due to coinciding HIV or HBV infection in the healthy
individuals, could be excluded. Only one individual
showed serological markers of a previous HBV infec-
tion. Furthermore, the possibility of artifacts has to be
considered, especially for the 'longer than expected
fragments'. Unspecific pick-ups during PCR can be due
to annealing of primers to target sequences with a low
degree of homology. However: we conducted the PCR
at higher annealing temperatures: 58 °C, 60 °C and
62 °C. Yet, the resulting pattern of fragments after gel
electrophoresis remained the same. After applying the
hot start PCR procedure there was also no change in the
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pattern of fragments. Additional fragments of 'longer
than expected length' were reproducibly seen at certain
positions for only some of the individuals assayed, e. g.
subject 2, figure 2 (not in others!), and HeLa and MT2
cells, thus excluding random unspecific priming at se-
quences unrelated to the corresponding primer sites. The
position of the longer than expected fragments amplified
from the DNA of those individuals remained identical
for some weeks, yet 16 months and 40 months later it
had been replaced by others or had disappeared (see data
for case 2, fig. 2a, c). From the results of these additional
controls and follow up, we infer that the primers used
have a high degree of homology with certain sections of
the human target DNA allowing them to anneal even at
higher temperatures, i. e. stringency. Therefore, the frag-
ments of expected, as well as of longer than expected,
length in some individuals can be ascribed to sequence
sections contained in the human DNA.
The findings available so far lend support to the assump-
tion that not all parts necessary for the generation of
an active process are present in every individual. HCV
specific DNA sequences have already been detected in
serum and plasma, especially of patients suffering from
severe chronic hepatitis C (probably due to DNA re-
leased from destroyed hepatocytes (7)) as well as HCV-
RNA in serum samples of healthy anti-HCV negative
individuals. One individual (sample 2, fig. 2) already
showed an additional 'longer fragment' beside the one
of expected length in her plasma upon reverse tran-
scriptase PCR assay. This indicates that
i) already in some 'healthy', anti-HCV negative individ-
uals HCV-RNA can be detected with the highly sensitive
reverse transcriptase PCR assay, and
ii) 'longer than expected' RNA-fragments (!) can also
be present.
With respect to these findings, HCV-RNA occasionally
detected in individuals without any signs of liver dis-
ease, such as elevated serum transaminases — without
anti-HCV antibodies — would represent some kind of
naturally (?) occuring transcripts of the human DNA.
To some extent, our findings could reflect the situation
insinuated by Miyakawa et al. (8) with respect to the
HGV — supposed to be a virus, but without harboring a
sequence that could code for a core — as to potentially
being an 'accidental tourist'. Conceivable within the
framework of a hypothesis, completion of dispersed se-
quences could either be achieved by exogenous 'infec-
tion' with transmissible protected structures containing
other lacking segments, DNA or RNA in nature and/or
internally by a process such as 'DNA rearrangement'.
Depending on incoming or sequences already present
this could constitute a situation enabling an active pro-
cess. The mechanism whereby structures can be estab-
lished with self-supporting and 'infectious' activities re-
mains to be determined. The possibility of a 'DNA-re-
arrangement' is inferred from the changing pattern of
fragments of longer than expected length after following
up individual 2 (sample 2, lane 6 to 9, fig. 2a, and lane
3, fig. 2c): At least two other additional fragments of
higher molecular mass than expected were present after
16 months (not shown here), and only one additional
fragment of longer than expected length 40 months later.
This situation could hint at HCV DNA sequence re-
arrangements during the course of time.
These findings, demonstrating HCV-specific sequences
of the 5TSTC as well as the core-region to be resident in
human DNA, do not harmonize with the current concept
of HCV as a conventional positive single-stranded RNA
virus. The findings that the HCV shares amino acid se-
quence similarities with plant viruses points to the com-
plex situation of an 'elusive agent', indicating a possible
recombinant source (9). Furthermore, a short, yet impor-
tant sequence of the long terminal repeat of HIV (10)
could be localized in some, yet not all (!) genotypes of
HCV. Recent findings (11, 12) describing a so far un-
known sequence of 98 nucleotides at the 3' terminus
have also created an unusual situation.
Very tentatively, our results could be interpreted to mean
that the HCV specific DNA sequences found and ana-
lyzed here represent naturally occuring constituents of the
human DNA. Whether they represent essential prerequi-
sites or only contribute to the broad spectrum of situations
caused by or associated with HCV remains to be deter-
mined. Findings of partial HCV core/GOR47-l aminoa-
cid homologies (13 — 15), where the coding sequence for
GOR37-1 is part of human DNA (16), already demon-
strate such a situation. Although speculative, our findings
would theoretically point to at least some 'HCV DNA se-
quences' being part of a system like human endogenous
DNA sequences. This would be similar to a situation com-
parable with that of the cellular homologue for hepatitis
delta antigen (17) or the endogenous retroviral related se-
quences, HERV (18). The virus-like particles occasion-
ally found in 'HCV infected' cells (19) would not contra-
dict the findings presented here: e. g., virus-like particles
originated from endogenous retroviral related sequences
can also be found (20). In consequences, this hypothesis
could be helpful in developing models for a possible caus-
ative role of 'HCV in, e. g., its association with autoim-
mune phenomenons or disorders (21-23) and hepatocel-
lular carcinomas (3). Further steps must be taken, such as
one to characterize sequences flanking those found in the
present study, and to identify the location of the HCV spe-
cific sequences found: chromosomal or any kind of epi-
somal structure.
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